| Basics |
|
Bionano Genomics, Inc.
|
| IPO Date: |
September 21, 2018 |
| Sector: |
Healthcare |
| Industry: |
Diagnostics and Research |
| Market Cap: |
$17.1M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.12 | 4.51%
|
| Avg Daily Range (30 D): |
$0.05 | 2.89%
|
| Avg Daily Range (90 D): |
$0.10 | 3.75%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
8.01M |
| Avg Daily Volume (30 D): |
.27M |
| Avg Daily Volume (90 D): |
.5M |
| Trade Size |
| Avg Trade Size (Sh.): |
364 |
| Avg Trade Size (Sh.) (30 D): |
159 |
| Avg Trade Size (Sh.) (90 D): |
187 |
| Institutional Trades |
| Total Inst.Trades: |
870 |
| Avg Inst. Trade: |
$1.76M |
| Avg Inst. Trade (30 D): |
$.7M |
| Avg Inst. Trade (90 D): |
$.7M |
| Avg Inst. Trade Volume: |
M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.59M |
| Avg Closing Trade (30 D): |
$.7M |
| Avg Closing Trade (90 D): |
$.7M |
| Avg Closing Volume: |
.98K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-12.68
|
$-1.59
|
$-1.99
|
|
Diluted EPS
|
$-12.68
|
$-1.59
|
$-1.99
|
|
Revenue
|
$ 28.72M
|
$ 7.37M
|
$ 6.73M
|
|
Gross Profit
|
$ 13.2M
|
$ 3.37M
|
$ 3.48M
|
|
Net Income / Loss
|
$ -38.59M
|
$ -8.5M
|
$ -6.86M
|
|
Operating Income / Loss
|
$ -36.74M
|
$ -8.54M
|
$ -7.8M
|
|
Cost of Revenue
|
$ 15.52M
|
$ 4M
|
$ 3.26M
|
|
Net Cash Flow
|
$ -6.13M
|
$ -.5M
|
$ -.06M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Jan 27, 2025:
1:60
|
|
Aug 07, 2023:
1:10
|
|
|
|